Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma.

Ludwig, H; Hajek, R; Tóthová, E; Drach, J; Adam, Z; Labar, B; Egyed, M; Spicka, I; Gisslinger, H; Greil, R; Kuhn, I; Zojer, N; Hinke, A; BLOOD. 2009; 113(15): 3435-3442.

The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells.

Nevo, I; Sagi-Assif, O; Meshel, T; Ben-Baruch, A; Jöhrer, K; Greil, R; Trejo, LE; Kharenko, O; Feinmesser, M; Yron, I; Witz, IP; Cancer Lett. 2009; 273(1): 127-139.

Vincristine, idarubicin, dexamethasone and thalidomide in scleromyxoedema.

Laimer, M; Namberger, K; Massone, C; Koller, J; Emberger, M; Pleyer, L; Hintner, H; Greil, R; Acta Derm Venereol. 2009; 89(6): 631-635.

Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.

Taylor, N; Schmid, I; Egle, A; Greil, R; Patsch, W; Oberkofler, H; Antivir Ther. 2009; 14(8): 118-193.

Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?

Gnant, M; Dubsky, P; Fitzal, F; Blaha, P; Schoppmann, S; Steger, G; Marth, C; Samonigg, H; Hüttner, K; Fohler, H; Ruecklinger, E; Jakesz, R; Greil, R; CLIN BREAST CANCER. 2009; 9 Suppl 1: S18-S27.

Novel therapeutics approaches to chronic lymphocytic leukemia based on recent biological insights.

Hartmann, TN; Pleyer, L; Desch, P; Egle, A; Greil, R; Discov Med. 2009; 8(42): 157-164.

The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer.

Bartsch, R; Mlineritsch, B; Gnant, M; Niernberger, T; Pluschnig, U; Greil, R; Wenzel, C; Sevelda, P; Thaler, J; Rudas, M; Pober, M; Zielinski, CC; Steger, GG; Breast Cancer Res Treat. 2009; 115(2):373-380

Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung cancer.

Pfeiffer, M; Hartmann, TN; Leick, M; Catusse, J; Schmitt-Graeff, A; Burger, M; BRIT J CANCER. 2009; 100(12): 1949-1956.

Single-point mutations causing more than 100-fold underestimation of human immunodeficiency virus type 1 (HIV-1) load with the Cobas TaqMan HIV-1 real-time PCR assay.

Korn, K; Weissbrich, B; Henke-Gendo, C; Heim, A; Jauer, CM; Taylor, N; Eberle, J; J Clin Microbiol. 2009; 47(4): 1238-1240.

Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot study.

Greil, R; Moik, M; Reitsamer, R; Ressler, S; Stoll, M; Namberger, K; Menzel, C; Mlineritsch, B; EJSO-EUR J SURG ONC. 2009; 35(10): 1048-1054.